Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, especially for cancers where treatment method options remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/3-tokens-below-1-that-can-grow-20x-in-february-2025/